Analysts think LSTA stock price could increase by 403%
Nov 27, 2024, 12:26 PM
10.21%
What does LSTA do
Lisata Therapeutics, based in Basking Ridge, New Jersey, focuses on developing therapies for advanced solid tumors, with its lead candidate LSTA1 enhancing anti-cancer drug penetration in tumors. The company also explores CD34+ cell therapy for various diseases, including critical limb ischemia and diabetic kidney disease.
4 analysts think LSTA stock price will increase by 402.82%. The current median analyst target is $14.28 compared to a current stock price of $2.84. The lowest analysts target is $13.13 and the highest analyst target is $15.75.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
